Our Mission

Our mission is to enable the first point of contact in the healthcare system to immediately identify sepsis and other medical conditions, and to facilitate the most appropriate treatment.

 

By bringing time-critical tests to the point of care, we aim to:

  • Facilitate faster diagnosis by reducing the time from infection to diagnosis
  • Reduce the time, distance, and cost barriers for people to get diagnosed
  • Identify unknown or underlying conditions earlier

For us, success means a faster path to disease diagnoses and treatment globally that will:

  • Make it easier to treat serious illnesses and reduce their long-term impact
  • Decrease patients’ time living with painful or life-threatening conditions
  • Reduced medical costs
  • Widespread accessibility to routine tests and screening

Leadership Team

David Deetz – Co-founder, CEO and Board Member

David has previously founded two other medical device companies, one of which completed a successful IPO on NASDAQ and Deloitte identified as one of the fastest-growing medical device companies in the nation. The other was acquired by Danaher/Radiometer as an important part of its POC product line. The author of 11 U.S. patents, David has raised $140 million in private and public capital for his companies.

Barbara Roth – Co-founder, COO, VP Manufacturing

Barbara is a former medical technologist previously involved in two successful POC blood-testing startups, one of which was purchased by J&J. The other, Diametrics Medical, where she served as vice president of manufacturing, went public on NASDAQ. She also served as manager of quality and regulatory affairs at Johnson & Johnson. At Ativa, Barbara is responsible for team coordination, quality systems, regulatory strategy, clinical studies, ongoing operations and overall manufacturing operations.